feed rss
decorazione
Star Alliance

FREE COMMUNICATION 03

 

ROOM HISAR     08:45 - 10:15

 

Encapsulating peritoneal sclerosis

 

 

Chairs: Soner Duman, Izmir, Turkey
             Olof Heimbürger, Stockholm, Sweden



SO019
T-HELPER CELLS AND FIBROSIS-ASSOCIATED MACROPHAGES DOMINATE THE PERITONEAL INFLAMMATORY INFILTRATE IN EPS PATIENTS
S M. Habib,1 A C Abrahams,2 M R Korte,3 M Clahsen-Van Groningen,4 M Gh Betjes.1 1Nephrology, Erasmus Medical Center, Rotterdam, Netherlands; 2Nephrology, UMC Utrecht, Utrecht, Netherlands; 3Nephrology, Albert Schweizer Hosp, Dordrecht, Netherlands; 4Pathology, Erasmus Medical Center, Rotterdam, Netherlands.
 
SO020
THE PREDICTIVE VALUE OF PERITONEAL EFFLUENT MMP-2 AND PAI-1 IN PD PATIENTS WHO DEVELOP ENCAPSULATING PERITONEAL SCLEROSIS
Deirisa Lopes Barreto,1 Dirk G Struijk,1,2 Raymond T Krediet.1 1Internal Medicine, Div Nephrology, Academic Medical Center, Univ Amsterdam, Amsterdam, Netherlands; 2Dianet Foundation, Amsterdam-Utrecht, Netherlands.
 
SO021
CCN2 (CTGF) IS HIGHLY EXPRESSED IN PERITONEUM OF PATIENTS WITH ENCAPSULATING PERITONEAL SCLEROSIS (EPS)
A C Abrahams,1 S M Habib,2 A Dendooven,3 D M Van Der Giezen,3 K Garchow,4 R J Toorop,5 C Je Watson,6 W H Boer,1 B L Riser,4 T Q Nguyen.3 1Nephrology, UMCU, Utrecht, Netherlands; 2Nephrology, Erasmus MC, Rotterdam, Netherlands; 3Pathology, UMCU, Utrecht, Netherlands; 4Physiology and Biophysics, Rosalind Franklin Univ Medicine and Science, Chicago, USA; 5Surgery, UMCU, Utrecht, Netherlands; 6Surgery, Addenbrooke’s Hosp, Cambridge, UK.
 
SO022
GADOLINIUM DEPOSITS IN THE PERITONEAL MEMBRANE- SECOND-HIT FOR DEVELOPMENT OF ENCAPSULATING PERITONEAL SCLEROSIS?
Joerg Latus,1 Peter Fritz,2 Christoph Ulmer,3 Stephan Segerer, 4 Dominik Alscher,1 Niko Braun.1 1Dept Internal Medicine, Div Nephrology, 2Dept Diagnostic Medicine, Div Pathology, 3Surgery, Robert-Bosch Hosp, Stuttgart, Germany; 4Div Nephrology, Univ Hosp Zurich, Zurich, Switzerland.

SO023
TRANSIENT FLUID FLOW STRESS AFFECTS THE KINETICS OF MESOTHELIAL CELLS AFTER ABRUPT DISCONTINUATION: POSSIBLE ROLE IN EPS AFTER WITHDRAWAL FROM PERITONEAL DIALYSIS
Shigehisa Aoki,1 Junichi Makino,2 Mitsuru Noguchi,3 Shuji Toda.1 1Pathology, Saga Univ, Saga, Japan; 2Urology, Makino Clinic, Saga, Japan; 3Urology, Saga Univ, Saga, Japan.

SO024
ENCAPSULATING PERITONEAL SCLEROSIS IN CHILDREN ON CHRONIC PD – A SURVEY FROM THE EUROPEAN PAEDIATRIC DIALYSIS WORKING GROUP
Rukshana Shroff,1 Constantinos Stefanidis,2 Alberto Edifonti, 3 Mesiha Ekim,4 Gema Ariceta,5 Sevcan Bakkaloglu,6 Michel Fischbach,7 Gunter Klaus,8 Aleksandra Zurowska,9 Claus Peter Schmitt,10 Alan Watson.11 1Great Ormond Street Hosp Children, London, UK; 2A & P Kyriakou Children’s Hosp, Athens, Greece; 3Clinica Pediatrica De Marchi, Milan, Italy; 4Ankara Univ Hosp, Ankara, Turkey; 5Hosp Cruces, Barakaldo, Vizcaya, Spain; 6Gazi Univ Hosp, Ankara, Turkey; 7Hop Hautepierre, Strasbourg, France; 8KfH Pediatric Kidney Center, Marburg, Germany; 9Univ Hosp, Gdansk, Poland; 10Center Pediatric & Adolescent Medicine, Heidelberg, Germany; 11Univ Hosp, Nottingham, UK.

 

back to the timetable

final programme "day by day" - may 18 - 21, 2013

today